62 related articles for article (PubMed ID: 16289906)
1. Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.
Lawton CA; Bae K; Pilepich M; Hanks G; Shipley W
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):437-41. PubMed ID: 17881145
[TBL] [Abstract][Full Text] [Related]
2. Treatment of low-risk prostate cancer: a retrospective study with 477 patients comparing external beam radiotherapy and I-125 seeds brachytherapy in terms of biochemical control and late side effects.
Moll M; Paschen C; Zaharie A; Berndl F; Goldner G
Strahlenther Onkol; 2021 Feb; 197(2):118-123. PubMed ID: 32642874
[TBL] [Abstract][Full Text] [Related]
3. Genitourinary toxicity in patients receiving TURP prior to hypofractionated radiotherapy for clinically localized prostate cancer: A scoping review.
Neerhut T; Grills R; Lynch R; Preece PD; McLeod K
Urol Oncol; 2024 Jun; 42(6):165-174. PubMed ID: 38503591
[TBL] [Abstract][Full Text] [Related]
4. Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer.
Moll M; Renner A; Kirisits C; Paschen C; Zaharie A; Goldner G
Strahlenther Onkol; 2021 Nov; 197(11):986-992. PubMed ID: 34351453
[TBL] [Abstract][Full Text] [Related]
5. ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
Rodda S; Tyldesley S; Morris WJ; Keyes M; Halperin R; Pai H; McKenzie M; Duncan G; Morton G; Hamm J; Murray N
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):286-295. PubMed ID: 28433432
[TBL] [Abstract][Full Text] [Related]
6. Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer.
Hoskin PJ; Rojas AM; Bownes PJ; Lowe GJ; Ostler PJ; Bryant L
Radiother Oncol; 2012 May; 103(2):217-22. PubMed ID: 22341794
[TBL] [Abstract][Full Text] [Related]
7. A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate.
Fischer-Valuck BW; Gay HA; Patel S; Baumann BC; Michalski JM
Front Oncol; 2019; 9():1378. PubMed ID: 31921640
[TBL] [Abstract][Full Text] [Related]
8. Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.
Moghanaki D; Turkbey B; Vapiwala N; Ehdaie B; Frank SJ; McLaughlin PW; Harisinghani M
Semin Radiat Oncol; 2017 Jan; 27(1):21-33. PubMed ID: 27986208
[TBL] [Abstract][Full Text] [Related]
9. Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapy.
Wernicke AG; Shamis M; Yan W; Trichter S; Sabbas AM; Goltser Y; Christos PJ; Brennan JS; Parashar B; Nori D
Urology; 2012 May; 79(5):1098-104. PubMed ID: 22546388
[TBL] [Abstract][Full Text] [Related]
10. Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809.
Hurwitz MD; Halabi S; Archer L; McGinnis LS; Kuettel MR; DiBiase SJ; Small EJ
Cancer; 2011 Dec; 117(24):5579-88. PubMed ID: 22535500
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321.
Hsu IC; Bae K; Shinohara K; Pouliot J; Purdy J; Ibbott G; Speight J; Vigneault E; Ivker R; Sandler H
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):751-8. PubMed ID: 20207506
[TBL] [Abstract][Full Text] [Related]
12. Current status and perspectives of brachytherapy for prostate cancer.
Yoshioka Y
Int J Clin Oncol; 2009 Feb; 14(1):31-6. PubMed ID: 19225921
[TBL] [Abstract][Full Text] [Related]
13. Role of androgen ablation with low-dose-rate brachytherapy in the treatment of prostate cancer.
Jani AB; Shoushtari A; Feinstein JM
Clin Drug Investig; 2006; 26(12):723-31. PubMed ID: 17274679
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019.
Lee WR; DeSilvio M; Lawton C; Gillin M; Morton G; Firat S; Baikadi M; Kuettel M; Greven K; Sandler H
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):804-9. PubMed ID: 16289906
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
Lawton CA; Yan Y; Lee WR; Gillin M; Firat S; Baikadi M; Crook J; Kuettel M; Morton G; Sandler H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e795-801. PubMed ID: 22330999
[TBL] [Abstract][Full Text] [Related]
16. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019.
Lee WR; Bae K; Lawton C; Gillin M; Morton G; Firat S; Baikadi M; Kuettel M; Greven K; Sandler H
Cancer; 2007 Apr; 109(8):1506-12. PubMed ID: 17340591
[TBL] [Abstract][Full Text] [Related]
17. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy in prostate cancer: improvements in an effective treatment and future prospects of further gains.
Milito SJ; Turrisi AT
J S C Med Assoc; 2000 Feb; 96(2):65-8. PubMed ID: 10710902
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
